 |
|
Empire Neurology, P.C.
|
|
Alzheimers Memory Center of Northeastern New York
|
|
|
|
Clinical Trials
Empire Neurology
continues to participate in the diagnosis and management of memory disorders, especially Alzheimer’s disease.
As reported in the New York Times front page articles on Saturday, July 17th recently, early treatment may make
a real difference. The New York Times article entitled: Drug Trials Test Bold Plan to Slow Alzheimer’s has
been a goal for many years.
Click here for NY times article
Now at Empire Neurology, 2 drug trials are on-going designed to reduce the burden of amyloid plaque in the brain.
Amyloid plaques has been known since the time of Dr. Alzheimer himself to be a basic part of the Alzheimer’s process.
Finally, there is hope that, in addition to standard medications such as Aricept, Exelon and Namenda, there may be treatments
that can slow the disease process not just treat the symptoms.
If
you wish to enroll for any of these studies or have any questions about the studies, please call our office at 518-785-1000.
|
|
|
1. AAB-001-SC-ALZ-2003
Janssen Alzheimer Immunotherapy
A phase II, randomized, double-blind, placebo-controlled,
parallel group, multicenter, biomarker, safety and pharmacokinetic study of bapinezumab (AAB-001) administered subcutaneously
at monthly intervals in subjects with mild to moderate Alzheimer's disease.
Click here for more information
2. ABE4869g Genentech,
Inc
A randomized, double-blind, placebo-controlled,
parallel group, multicenter, phase II study to evaluate the efficacy and safety of MABT5102A in patients with mild to moderate
Alzheimer's disease.
|
|
|
|
|
|
|
Empire Neurology, P.C
Riverhill Center, Suite 105, 1205 Troy-Schenectady Road, Latham,
NY, US, 12110 Phone: 518-785-1000
|
|
|
